Cohance Lifesciences details annual report access and AGM plans

Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has informed shareholders about the web-link to access the company's annual report for the financial year ended March 31, 2025. This disclosure is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The web-link provided is https://www.suvenpharm.com/pdf/Investors/Financial-Info/Cohance_AnnualReport_2025.pdf.

The company's 7th annual general meeting (AGM) is scheduled for Friday, September 19, 2025, at 2:30 p.m. (IST) via video conference/other audio-visual means. Shareholders whose email addresses are not registered will receive a letter providing the direct web-link, while those with registered emails will receive the notice of AGM and annual report electronically.

Shareholders are also reminded to update their PAN, KYC details, bank account information, and nomination details. The company emphasizes that payments, including dividends, for folios without updated PAN or KYC will only be processed electronically once the required information is registered. A dedicated Senior Citizens Investor Cell has been established by the RTA to assist shareholders aged 60 and above, contactable at senior.citizen@kfintech.com or via toll-free number 1800 3094 006.